dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Sánchez-Heras, A. Beatriz |
dc.contributor.author | Castillejo, Adela |
dc.contributor.author | García-Díaz, Juan D. |
dc.contributor.author | Teulé, Alexandre |
dc.contributor.author | Sánchez, Rosario |
dc.contributor.author | Lopez Fernandez, Adrià |
dc.contributor.author | Balmaña Gelpí, Judith |
dc.contributor.author | Robledo, Mercedes |
dc.date.accessioned | 2021-08-27T08:50:12Z |
dc.date.available | 2021-08-27T08:50:12Z |
dc.date.issued | 2020-11-05 |
dc.identifier.citation | Sánchez-Heras AB, Castillejo A, García-Díaz JD, Robledo M, Teulé A, Sánchez R, et al. Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Spain: Clinical and Genetic Characterization. Cancers. 2020 Nov 5;12(11):3277. |
dc.identifier.issn | 2072-6694 |
dc.identifier.uri | https://hdl.handle.net/11351/6243 |
dc.description | Leiomiomatosi hereditària; Càncer de cèl·lules renals; Gen FH |
dc.description.sponsorship | This research received no external funding. |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | Cancers;12(11) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Cèl·lules canceroses |
dc.subject | Ronyons - Malalties - Espanya |
dc.subject.mesh | Leiomyomatosis |
dc.subject.mesh | /genetics |
dc.subject.mesh | Carcinoma, Renal Cell |
dc.subject.mesh | Spain |
dc.title | Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Spain: Clinical and Genetic Characterization |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/cancers12113277 |
dc.subject.decs | leiomiomatosis |
dc.subject.decs | /genética |
dc.subject.decs | carcinoma de células renales |
dc.subject.decs | España |
dc.relation.publishversion | https://www.mdpi.com/2072-6694/12/11/3277 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Sánchez-Heras AB] Cancer Genetic Counselling Unit, Medical Oncology Department, Hospital General Universitario de Elche, Elche, Spain. [Castillejo A] Molecular Genetics Unit, Hospital General Universitario de Elche, Elche, Spain. [García-Díaz JD] Clinical Genetics Unit, Department of Internal Medicine, University Hospital Príncipe de Asturias, Alcalá de Henares, Spain. [Robledo M] Hereditary Endocrine Cancer Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain. Centro de Investigación Biomédica en Red de Enfermedades Raras, CIBERER, Madrid, Spain. [Teulé A] Hereditary Cancer Program, Catalan Institute of Oncology, Instituto de Investigación Biomédica de Bellvitge, Hospitalet de Llobregat, Spain. [Sánchez R] Unidad Multidisciplinar de Enfermedades de Baja Prevalencia, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL), Hospital General Universitario de Alicante, Alicante, Spain. [López-Fernández A, Balmaña J] Hereditary Cancer Genetics Group, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain |
dc.identifier.pmid | 33167498 |
dc.identifier.wos | :000592895600001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |